The Calmer Co. International Ltd (ASX: CCO), a prominent player in the kava-based wellness and relaxation product sector, has successfully raised AU$1,000,713 through a renounceable rights issue. The offering, which closed on May 16, 2025, resulted in the issuance of over 333 million new shares and 166 million options, including allocations to the underwriter. Strong participation from shareholders and management underscores confidence in the company’s growth trajectory. The funds will support capital expenditure, inventory expansion, brand promotion, and general operations. Leveraging a strong presence in both online and retail markets across the USA, Australia, New Zealand, China, and the Pacific Islands, The Calmer Co. offers a diverse range of kava-infused products—including powders, ready-to-drink shots, liquid concentrates, and capsules—sold under its flagship brands Fiji Kava, Taki Mai, and Danodan Hempworks. The success of this fundraising reflects its ambition to scale its farm-to-shelf supply chain and capture the global demand for natural alcohol alternatives.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 13, 2025
Jun 12, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
